Home Cart Sign in  
Chemical Structure| 1334782-79-4 Chemical Structure| 1334782-79-4

Structure of PF-5190457
CAS No.: 1334782-79-4

Chemical Structure| 1334782-79-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PF 05190457 is a selective inverse agonist of ghrelin receptor with Kd of 3 nM.

Synonyms: PF-05190457

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PF-5190457

CAS No. :1334782-79-4
Formula : C29H32N6OS
M.W : 512.67
SMILES Code : [H][C@]1(CCC2=CC(C3=NC=NC(C)=C3)=CC=C12)N(C4)CC4(CC5)CCN5C(CC6=CN7C=C(C)SC7=N6)=O
Synonyms :
PF-05190457
MDL No. :MFCD28411390

Safety of PF-5190457

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Related Pathways of PF-5190457

GPCR

Isoform Comparison

Biological Activity

Description
PF-5190457 (PF-05190457) acts as a potent and selective inverse agonist for the ghrelin receptor, exhibiting a pKi value of 8.36[1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02039349 Alcoholism|Alcohol-Related Dis... More >>orders|Alcohol Dependence|Alcohol Drinking Related Problems|Alcohol Drinking Less << PHASE1 COMPLETED 2017-12-24 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.95mL

0.39mL

0.20mL

9.75mL

1.95mL

0.98mL

19.51mL

3.90mL

1.95mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories